Generation Bio Co.
CLOSED-ENDED DNA (CEDNA) AND IMMUNE MODULATING COMPOUNDS
Last updated:
Abstract:
Provided herein are methods and constructs related to minimizing immune responses using modified dexamethasone compounds when administering a desired transgene in a cell achieved by delivery of the transgene with one or more doses of a ceDNA construct.
Status:
Application
Type:
Utility
Filling date:
6 Mar 2020
Issue date:
16 Jun 2022